February 24, 2012 — CardioFocus Inc., developer of the HeartLight Endoscopic Ablation System (EAS) for the treatment of atrial fibrillation (AF), announced the first patient has been enrolled and treated in the HeartLight EAS U.S. pivotal trial, designed to evaluate the safety and efficacy of the technology in treating symptomatic AF.

The U.S. Food and Drug Administration (FDA) granted the first coronary stent indication for use in patients experiencing an acute myocardial infarction (AMI), or heart attack. The Boston Scientific Ion paclitaxel-eluting stent system and Taxus Liberte paclitaxel-eluting stent system are now the only drug-eluting stents (DES) in the United States with an approved indication to treat patients with AMI.

February 24, 2012 — For the first time in years, information technology (IT) leaders at healthcare organizations did not identify a lack of financial support for IT as an obstacle to implementation; instead, concerns about staffing resources was cited as the key barrier.


Computed tomography (CT) and advanced visualization software has allowed researchers to vitually unwrap a 2000-year-old mummy at the National Museums Scotland. Together with a team of radiologists and a forensic pathologist from Edinburgh University, a great deal has been learned about this female mummy, who died when she was in her mid-to-late twenties.


February 23, 2012 – According to a new survey issued by the Heart Rhythm Society (HRS), the majority of Americans are unaware of two serious and potentially life-threatening heart rhythm disorders, atrial fibrillation (AF) and sudden cardiac arrest (SCA).

February 23, 2012 — AstraZeneca announced that the American College of Chest Physicians (ACCP) has updated its guidelines on Antithrombotic Therapy and Prevention of Thrombosis to include a recommendation for giving the oral antiplatelet medicine, BRILINTA (ticagrelor) tablets with low-dose aspirin, to patients who suffer from acute coronary syndrome (ACS).

Teleflex Inc. announced a new agreement with HealthTrust Purchasing Group L.P. (HealthTrust), for its Arrow Intra-Aortic Balloon Pump and Catheter products. The new agreement begins March 1, 2012 and extends through Feb. 28, 2015.

February 23, 2012 — At the European Congress of Radiology taking place March 1-5, Spellman High Voltage Electronics Corp. and K&S Röntgenwerk will exhibit together for the first time at the Austria Center Vienna under the name Spellman High Voltage GmbH.

Subscribe Now